561 results on '"Hydralazine adverse effects"'
Search Results
502. [Rheumatogenic action of hydralazine (apresoline)].
503. Polyneuritis occurring during hydralazine therapy; report of two cases and discussion of adverse reactions to hydralazine.
504. Immune responses to hydralazine and nuclear antigens in hydralazine-induced lupus erythematosus.
505. [Frequency of hematologic side effects in antihypertensive long-term therapy].
506. Occupational dermatitis from hydrazine hydrate used in boiler protection. Cross sensitization to apresoline, isoniazid and phenelzine.
507. Some effects of hydralazine on hypertensive patients with impaired kidney function.
508. [Antinuclear factors. Demonstration and clinico-diagnostic significance].
509. Drug-induced lupus erythematosus.
510. Medical management of primary hypertension. 2.
511. [Evaluation of antihypertensive therapy with Adelphan-Esidrex by clinical and psychometric parameters].
512. [Iatrogenic lupus: current status of the question. I. Clinical study and main drugs responsible].
513. Hypertension; precaution in treatment.
514. [Kidney diseases caused by drugs].
515. Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine.
516. [Acute renal insufficiency during hydrazinophthalazine therapy of chronic renal insufficiency].
517. Drug-induced lupus syndromes.
518. [Collagenoses. VI. A case of acute disseminated lupus erythematosus following prolonged therapeutic administration of hydralazine].
519. [The pathogenesis of systemic lupus erythematosus (experimental research)].
520. Hydralazine (Apresoline) lupus with fatal renal failure.
521. [Hydralazine-induced lupus erythematosus].
522. A case of hypertension and systemic lupus erythematosus.
523. Cutaneous reactions to cardiovascular drugs.
524. Drug-induced lupus syndromes.
525. Antinuclear antibodies following hydralazine toxicity.
526. Pyridoxine-deficiency neuropathy due to hydralazine.
527. [The present situation of treatment of hypertension].
528. [Pharmacological basis of the symptomatic treatment of arterial hypertension. I. Hemodynamic effects, mechanisms of action and side effects of antihypertensive agents].
529. [Activation of lupus erythematosus disseminatus caused by drugs].
530. [Collagenoses. VII. Clinical study of hydralazinic lupus erythematosus].
531. [Iatrogenic lupus: present status of the problem. II. Physiopathology of induced lupus].
532. [Relation to rheumatoid arthritis of hydralazine disease & arthritis accompanying gross abnormalities of gamma globulin].
533. [Drug-induced lupus erythematosus disseminatus].
534. [A difficult diagnosis?].
535. Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus.
536. Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis.
537. [Death following wrong medications].
538. Drug-induced systemic lupus erythematosus.
539. [Acute immunologic hydralazine reaction. Clinical and serological changes after hydralazine administration to a patient with circulating antinuclear antibodies].
540. Pericardial tamponade: a major presenting manifestation of hydralazine-induced lupus syndrome.
541. [Side effects of drugs. 4. Drug induced polyneuropathies and myopathies].
542. [Secondary effects of hypotensive drugs in arterial hypertension of renal origin].
543. [Lupus induced by isoniazid].
544. [Hydralazine syndrome].
545. Drug therapy of hypertension.
546. Antinuclear antibodies.
547. Pathomechanism of the side-effects of hydralazine.
548. Combined dihydralazine and propranolol in the treatment of hypertension.
549. Reserpine, hydralazine, hydrochlorothiazide combination (Ser-AP-ES) in essential hypertension.
550. Immunologic findings in patients receiving methyldopa: a prospective study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.